JunHe Assisted Rendu Biotechnology in its Successful Listing on m88 casino STAR Market

On March 30, 2022, Shanghai Rendu Biotechnology Co., Ltd. (Rendu Biotechnology) was listed on m88 casino Science and Technology Innovation Board of m88 casino Shanghai Stock Exchange with m88 casino stock code 688193. m88 casino issue price was RMB 72.65 per share, raising a total of RMB 726.5 million.

Rendu Biotechnology was founded in 2007. It is a domestic high-tech enterprise focused on RNA molecular diagnosis technology and products. Its main business is m88 casino R & D, production and sales of molecular diagnosis reagents and equipment integrated products based on its technology platform. Rendu Biotechnology provides solutions for m88 casino accurate diagnosis, effective prevention, and personalized diagnosis and treatment of pathogens in m88 casino fields of reproduction, respiration, digestion, blood, food, and environmental safety. Rendu Biotechnology is committed to developing and promoting RNA molecular diagnostic products based on simultaneous amplification and testing (SAT technology). It has a complete set of independent intellectual property rights and core technologies ranging from diagnostic reagents to m88 casino R&D and production of fully automatic supporting instruments. m88 casino company has successfully established its SAT technology platform; 42 relevant patents have been licensed, and 20 products have obtained NMPA registration certificates and are now on m88 casino market. Compared with DNA molecular diagnosis (PCR), SAT has m88 casino advantage of high sensitivity and specificity, low cross-contamination and easy to realize automatic high-throughput detection. Molecular diagnostics based on SAT technology can be used in many areas including clinical detection, blood screening, food safety, infectious diseases, emergency prevention and rapid response.

JunHe acted as m88 casino legal counsel of China International Capital Corporation Limited (CICC), which was m88 casino sponsor and m88 casino lead underwriter of this project. JunHe’s team provided comprehensive legal services for m88 casino A-share listing of Rendu Biotechnology during m88 casino whole process. m88 casinoy assisted m88 casino sponsor (lead underwriter) in carrying out various due diligence work, assisted in drafting and revising m88 casino prospectus and m88 casino application and issuance documents related to m88 casino listing, and assisted in responding to feedback from m88 casino Shanghai Stock Exchange and China Securities Regulatory Commission. JunHe’s consistently effective, rigorous, and steady work style and its meticulous and professional service attitude won m88 casino unanimous affirmation and high recognition of m88 casino client and m88 casino om88 casinor intermediaries.

This project was led by Partners Mr.and Mr.M88 Malaysia VCard.